The safety and accurate identification of reproductive material are fundamental requirements in every IVF treatment.
Ovagenesis collaborates with Institute of Life – IASO, where assisted reproduction treatments are supported by modern clinical and laboratory facilities, organised procedures and quality-control systems.
Within this framework, RI Witness is used as an electronic identification and traceability system specifically designed for assisted reproduction units. The system supports the electronic matching of patients with their reproductive material and its monitoring throughout the main stages of treatment.
This technology works alongside the checks performed by the specialised scientific team, adding an additional level of safety and documentation throughout the treatment process.
What does traceability mean in IVF?
Traceability means that reproductive material remains connected to the details of the patient or couple throughout the entire course of treatment.
This applies to eggs, sperm samples and embryos, from collection and fertilisation through to culture, cryopreservation or embryo transfer.
The objective is for every stage to be carried out with clear identification, documented recording and repeated verification.
Traceability is not a single action. It is a continuous process that follows the reproductive material throughout the treatment journey.
What is RI Witness?
RI Witness is an electronic witnessing system used to verify and match the samples involved in IVF treatment.
Through electronic identification, the system helps confirm that the reproductive material and the associated laboratory items correspond to the correct patient or couple.
At the same time, it supports the organised electronic recording of key stages of the process and reinforces the overall chain of traceability.
RI Witness does not replace the scientific team. It acts as an additional safeguard within a broader framework of checks and quality procedures.
Why is electronic identification important?
IVF involves multiple stages and the management of particularly sensitive biological material.
Electronic identification adds another level of verification to the unit’s established procedures. It supports accurate matching of information, systematic documentation and the early recognition of potential discrepancies.
Its value lies not only in the technology itself, but in the way it is integrated into an overall system of safety and quality.
Why does technology not replace the scientific team?
Technology is a supporting tool, not a substitute for human responsibility.
Safety is based on the combination of:
- specialised personnel,
- organised procedures,
- systematic checks,
- electronic traceability,
- modern clinical and laboratory facilities,
- continuous quality control.
The experience of the scientific team, the correct application of procedures and technological support all work together.
RI Witness strengthens this framework by providing an additional level of electronic verification and documentation.
The importance of the collaboration with Institute of Life – IASO
Ovagenesis’ collaboration with Institute of Life – IASO allows treatments to take place within an organised assisted reproduction environment, supported by modern facilities and technologies that promote safety and quality.
The use of RI Witness forms part of this framework and strengthens the identification and traceability of reproductive material throughout treatment.
For Ovagenesis, collaboration with a specialised centre is not limited to the location where treatment is carried out. It provides access to an integrated clinical and laboratory infrastructure that supports the personalised treatment plan of each patient and couple.
What does this mean for the patient?
For the patient, the use of an electronic identification system provides greater transparency and an additional level of safety during a particularly demanding treatment process.
The most important factor is not the technology in isolation, but the way it is incorporated into an overall framework of scientific supervision, quality control and responsible management.
Knowing that treatment is supported by modern traceability systems may also strengthen the patient’s sense of trust and security during a process that is often associated with significant emotional strain.
Safety as part of personalised care
Personalised treatment is not limited to the selection of the appropriate medical protocol.
It also includes the environment in which treatment takes place, the procedures supporting each stage and the technologies that contribute to the safe management of reproductive material.
The collaboration between the Ovagenesis medical team and Institute of Life – IASO makes it possible to combine a personalised clinical approach with modern technological support.
The Ovagenesis approach
At Ovagenesis, each treatment plan is developed according to the medical history, needs and individual characteristics of every patient or couple.
The collaboration with Institute of Life – IASO provides access to an integrated assisted reproduction environment in which scientific expertise is combined with modern facilities and technological safety systems.
The use of RI Witness forms part of this framework and supports the safe identification and traceability of reproductive material.
The objective is for every stage of treatment to be carried out with scientific accuracy, responsible management and clear communication with the patient.
Conclusion
The accurate identification of eggs, sperm and embryos is a fundamental part of modern IVF treatment.
Through its collaboration with Institute of Life – IASO, Ovagenesis combines a personalised treatment plan with modern facilities and the RI Witness electronic system.
Electronic traceability adds an important level of verification and documentation without replacing the role and responsibility of the scientific team.
Safety in IVF is based on the combination of specialised personnel, organised procedures, modern technology and continuous quality control.
